United Guardian Inc (UG) is the 258th largest of 300 Pharmaceuticals companies by market capitalisation, at 32.71 Mn, behind Actuate Therapeutics, Inc. at 32.72 Mn. It trades on a P/E of 14.46, 45% below the peer median of 26.19. The table below compares all 300 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 647.06 Bn | 30.76 | 6.61 | 626.30 Bn |
| 2 | ABBV | AbbVie Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 440.06 Bn | 69.67 | 6.83 | 433.49 Bn |
| 3 | MRK | Merck & Co., Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 364.19 Bn | 114.92 | 5.47 | 357.05 Bn |
| 4 | NVS | Novartis Ag | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 268.45 Bn | 9.32 | 3.91 | 260.76 Bn |
| 5 | PFE | Pfizer Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 158.40 Bn | 36.26 | 2.49 | 146.70 Bn |
| 6 | SNY | Sanofi | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 52.57 Bn | 11.28 | 0.98 | 45.19 Bn |
| 7 | RVMD | Revolution Medicines, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 44.32 Bn | -25.06 | — | 44.32 Bn |
| 8 | INCY | Incyte Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 24.98 Bn | 15.49 | 4.29 | 20.44 Bn |
| 9 | UTHR | UNITED THERAPEUTICS Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 21.15 Bn | 16.13 | 6.70 | 18.49 Bn |
| 10 | NBIX | Neurocrine Biosciences Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.44 Bn | 21.89 | 4.58 | 15.05 Bn |
| 11 | JAZZ | Jazz Pharmaceuticals plc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 14.99 Bn | 15.93 | 3.26 | 13.37 Bn |
| 12 | EXEL | Exelixis, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 14.29 Bn | 16.61 | 5.87 | 13.45 Bn |
| 13 | CORT | Corcept Therapeutics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 12.28 Bn | 226.58 | 14.78 | 11.97 Bn |
| 14 | KYMR | Kymera Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.58 Bn | -38.64 | 110.24 | 10.88 Bn |
| 15 | AXSM | Axsome Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.81 Bn | -70.31 | 13.92 | 10.49 Bn |
| 16 | NUVL | Nuvalent, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.75 Bn | -27.07 | — | 9.75 Bn |
| 17 | CYTK | Cytokinetics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.75 Bn | -13.29 | 144.02 | 8.58 Bn |
| 18 | GPCR | Structure Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.64 Bn | -51.25 | — | 9.64 Bn |
| 19 | CRNX | Crinetics Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.99 Bn | -17.90 | 213.22 | 8.99 Bn |
| 20 | ALKS | Alkermes plc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.57 Bn | 114.45 | 4.54 | 6.91 Bn |
| 21 | BLTE | Belite Bio, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.24 Bn | 0.09 | — | 6.24 Bn |
| 22 | TVTX | Travere Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.21 Bn | -142.94 | 10.51 | 6.09 Bn |
| 23 | LQDA | Liquidia Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.08 Bn | 43.85 | 13.48 | 5.79 Bn |
| 24 | AMRN | Amarin Corp Plc\Uk | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.93 Bn | -218.63 | 31.84 | 5.62 Bn |
| 25 | ACAD | Acadia Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.75 Bn | 12.49 | 4.17 | 3.80 Bn |
| 26 | EWTX | Edgewise Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.66 Bn | -23.61 | — | 4.66 Bn |
| 27 | DFTX | Definium Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.22 Bn | -11.92 | — | 4.22 Bn |
| 28 | INDV | Indivior Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.06 Bn | 11.43 | 3.05 | 3.84 Bn |
| 29 | MANE | Veradermics, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.00 Bn | -46.40 | — | 4.00 Bn |
| 30 | ELVN | Enliven Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.89 Bn | -46.28 | — | 3.89 Bn |
| 31 | CPRX | CATALYST PHARMACEUTICALS, INC. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.85 Bn | 17.94 | 6.45 | 3.09 Bn |
| 32 | TARS | Tarsus Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.69 Bn | -78.65 | 6.09 | 3.24 Bn |
| 33 | OGN | Organon & Co. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.61 Bn | 17.25 | 0.59 | 2.47 Bn |
| 34 | NAMS | NewAmsterdam Pharma Co N.V. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.95 Bn | -11.37 | 414.32 | 2.95 Bn |
| 35 | TAK | Takeda Pharmaceutical Co Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.62 Bn | 4.56 | 0.06 | -3.18 Bn |
| 36 | TRVI | Trevi Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.62 Bn | -62.01 | — | 2.62 Bn |
| 37 | MLYS | Mineralys Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.61 Bn | -7.47 | — | 2.61 Bn |
| 38 | BEIGF | BeOne Medicines Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.48 Bn | 3.74 | 0.40 | -2.62 Bn |
| 39 | SUPN | Supernus Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.44 Bn | -28.61 | 3.09 | 2.06 Bn |
| 40 | HRMY | Harmony Biosciences Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.42 Bn | 13.56 | 2.52 | 1.61 Bn |
| 41 | NUVB | Nuvation Bio Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.29 Bn | -21.21 | 13.50 | 2.29 Bn |
| 42 | PVLA | Palvella Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.20 Bn | -41.49 | — | 1.89 Bn |
| 43 | AUPH | Aurinia Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.10 Bn | 6.67 | 6.73 | 1.65 Bn |
| 44 | ETON | Eton Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.63 Bn | 171.11 | 16.30 | 1.61 Bn |
| 45 | INVA | Innoviva, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.56 Bn | 7.93 | 3.02 | 0.98 Bn |
| 46 | XERS | Xeris Biopharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.46 Bn | -85.28 | 4.36 | 1.34 Bn |
| 47 | LBRX | Lb Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.46 Bn | -24.09 | — | 1.46 Bn |
| 48 | HROW | Harrow, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.41 Bn | -42.00 | 5.10 | 1.32 Bn |
| 49 | OPK | Opko Health, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.19 Bn | -31.40 | 2.02 | 0.89 Bn |
| 50 | OLMA | Olema Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.11 Bn | -5.46 | — | 1.11 Bn |
| 51 | KURA | Kura Oncology, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.09 Bn | -4.57 | 14.07 | 1.09 Bn |
| 52 | PCRX | Pacira BioSciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.01 Bn | 68.74 | 1.35 | 0.76 Bn |
| 53 | LXRX | Lexicon Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.96 Bn | -15.28 | 23.17 | 0.77 Bn |
| 54 | DSGN | Design Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.96 Bn | -11.81 | — | 0.75 Bn |
| 55 | SGP | SpyGlass Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.94 Bn | -48.72 | — | 0.94 Bn |
| 56 | VSTM | Verastem, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.82 Bn | -7.13 | 9.40 | 0.69 Bn |
| 57 | COLL | Collegium Pharmaceutical, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.76 Bn | 15.88 | 0.94 | 0.61 Bn |
| 58 | PHAT | Phathom Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.74 Bn | -7.56 | 3.10 | 0.56 Bn |
| 59 | ZVRA | Zevra Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.73 Bn | 12.51 | 5.35 | 0.51 Bn |
| 60 | GYRE | Gyre Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.71 Bn | -38.66 | 5.98 | 0.66 Bn |
| 61 | IVEVF | Inventiva S.A. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.69 Bn | 7.19 | 132.94 | 0.69 Bn |
| 62 | CRMD | CorMedix Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | 5.12 | 1.72 | 0.39 Bn |
| 63 | AQST | Aquestive Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | -8.23 | 11.90 | 0.55 Bn |
| 64 | MPLT | MapLight Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.63 Bn | -3.10 | — | 0.63 Bn |
| 65 | EOLS | Evolus, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.58 Bn | -16.86 | 1.83 | 0.53 Bn |
| 66 | NVCT | Nuvectis Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.55 Bn | -18.08 | — | 0.55 Bn |
| 67 | OVID | Ovid Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -15.57 | 339.28 | 0.42 Bn |
| 68 | SPRY | ARS Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.53 Bn | -2.40 | 4.54 | 0.39 Bn |
| 69 | PALI | Palisade Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.45 Bn | -12.64 | 892.03 | 0.32 Bn |
| 70 | XFOR | X4 Pharmaceuticals, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -4.92 | 27.98 | 0.25 Bn |
| 71 | IKT | Inhibikase Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -6.48 | — | 0.27 Bn |
| 72 | VTVT | vTv Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -88.20 | 11.39 | 0.42 Bn |
| 73 | TTRX | Turn Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -53.19 | — | 0.41 Bn |
| 74 | SION | Sionna Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.34 Bn | -3.45 | — | 0.34 Bn |
| 75 | ACHV | Achieve Life Sciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.33 Bn | — | — | 0.33 Bn |
| 76 | VNDA | Vanda Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -1.15 | 1.47 | 0.15 Bn |
| 77 | IMRX | Immuneering Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.31 Bn | -5.25 | — | 0.31 Bn |
| 78 | EBS | Emergent BioSolutions Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -1.70 | 0.39 | 0.16 Bn |
| 79 | FULC | Fulcrum Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -3.25 | — | 0.29 Bn |
| 80 | ZNTL | Zentalis Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.28 Bn | -2.00 | — | 0.28 Bn |
| 81 | AKBA | Akebia Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.27 Bn | -9.04 | 1.22 | 0.11 Bn |
| 82 | CELG-RI | Bristol Myers Squibb Co | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | 0.03 | 0.00 | -10.83 Bn |
| 83 | SIGA | Siga Technologies Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | — | — | 0.07 Bn |
| 84 | TNXP | Tonix Pharmaceuticals Holding Corp. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -1.35 | 7.41 | 0.22 Bn |
| 85 | DERM | Journey Medical Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -57.23 | 3.07 | 0.18 Bn |
| 86 | ACOG | Alpha Cognition Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -7.49 | 15.36 | 0.16 Bn |
| 87 | NERV | Minerva Neurosciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -30.65 | — | 0.20 Bn |
| 88 | CRDL | Cardiol Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -7.54 | — | 0.20 Bn |
| 89 | SLGL | Sol-Gel Technologies Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -18.49 | 108.02 | 0.15 Bn |
| 90 | MCUJF | Medicure Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -37.45 | 8.18 | 0.19 Bn |
| 91 | LONA | LeonaBio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.18 Bn | -1.51 | — | 0.13 Bn |
| 92 | LENZ | LENZ Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.16 Bn | -1.26 | 7.58 | 0.16 Bn |
| 93 | MENS | Jyong Biotech Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.16 Bn | -46.69 | — | 0.16 Bn |
| 94 | BMEA | Biomea Fusion, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -2.36 | — | 0.13 Bn |
| 95 | VANI | Vivani Medical, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.12 Bn | -4.32 | — | 0.10 Bn |
| 96 | VRCA | Verrica Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -3.63 | 3.77 | 0.10 Bn |
| 97 | AARD | Aardvark Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -1.57 | — | 0.04 Bn |
| 98 | CPIX | Cumberland Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -9.14 | 3.15 | 0.09 Bn |
| 99 | TENX | Tenax Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -1.50 | — | 0.10 Bn |
| 100 | CGTX | Cognition Therapeutics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -2.50 | — | 0.09 Bn |
| 101 | MNOV | Medicinova Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -7.69 | 101.21 | 0.09 Bn |
| 102 | NTHI | Neonc Technologies Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -1.94 | — | 0.09 Bn |
| 103 | PTHS | Pelthos Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -0.77 | 1.60 | 0.06 Bn |
| 104 | RGC | Regencell Bioscience Holdings Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | — | — | 0.08 Bn |
| 105 | PMVP | PMV Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -1.21 | — | -0.01 Bn |
| 106 | PLRX | Pliant Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -0.77 | — | 0.07 Bn |
| 107 | BOLD | Boundless Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -1.01 | — | 0.06 Bn |
| 108 | VERU | Veru Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | 117.83 | — | 0.03 Bn |
| 109 | GOSS | Gossamer Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.30 | 0.97 | -0.01 Bn |
| 110 | KPTI | Karyopharm Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.25 | 0.33 | -0.02 Bn |
| 111 | ANVS | Annovis Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.97 | — | 0.05 Bn |
| 112 | CLNN | Clene Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -1.37 | 218.92 | 0.05 Bn |
| 113 | APRE | Aprea Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -3.50 | — | 0.04 Bn |
| 114 | IXHL | Incannex Healthcare Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.84 | — | 0.04 Bn |
| 115 | SCLX | Scilex Holding Co | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.08 | 1.18 | -0.08 Bn |
| 116 | GRCE | Grace Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -1.81 | — | 0.04 Bn |
| 117 | CPHI | China Pharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -7.59 | 8.68 | 0.03 Bn |
| 118 | ACTU | Actuate Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -1.57 | — | 0.03 Bn |
| 119 | UG | United Guardian Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 14.46 | 2.92 | 0.02 Bn |
| 120 | NSRX | Nasus Pharma Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -5.64 | — | 0.03 Bn |
| 121 | BYSI | BeyondSpring Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.06 | — | 0.03 Bn |
| 122 | CRVO | CervoMed Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -0.85 | 77.62 | 0.03 Bn |
| 123 | TXMD | TherapeuticsMD, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -137.95 | 7.80 | 0.02 Bn |
| 124 | YARW | Yarrow Bioscience, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.12 | 46.69 | 0.00 Bn |
| 125 | AYTU | Aytu Biopharma, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.75 | 0.40 | 0.00 Bn |
| 126 | ATOS | Atossa Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.74 | — | 0.02 Bn |
| 127 | BFRI | Biofrontera Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -4.39 | 0.46 | 0.02 Bn |
| 128 | ALLR | Allarity Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.69 | 817.81 | 0.02 Bn |
| 129 | MIRA | Mira Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.54 | — | 0.01 Bn |
| 130 | TVRD | Tvardi Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.68 | — | 0.02 Bn |
| 131 | CTXR | Citius Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.34 | 2.21 | 0.02 Bn |
| 132 | KPRX | Kiora Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.42 | — | 0.02 Bn |
| 133 | ANEB | Anebulo Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.64 | — | 0.01 Bn |
| 134 | INTI | Inhibitor Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -3.67 | — | 0.01 Bn |
| 135 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.78 | — | 0.01 Bn |
| 136 | CALC | CalciMedica, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.32 | -7.84 | -0.01 Bn |
| 137 | CURX | Curanex Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.89 | — | 0.00 Bn |
| 138 | ADXN | Addex Therapeutics Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | 0.05 | — | 0.01 Bn |
| 139 | ACXP | Acurx Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.81 | — | 0.01 Bn |
| 140 | TRAW | Traws Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.35 | — | 0.00 Bn |
| 141 | PULM | Pulmatrix, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.41 | — | 0.01 Bn |
| 142 | PCSA | Processa Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.42 | — | 0.01 Bn |
| 143 | TCRT | Alaunos Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.93 | 1,256.38 | 0.00 Bn |
| 144 | BICX | BioCorRx Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.64 | 6.70 | 0.00 Bn |
| 145 | CVKD | Cadrenal Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.29 | — | 0.00 Bn |
| 146 | CASIF | CASI Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.02 | 0.12 | 0.00 Bn |
| 147 | OGEN | Oragenics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.23 | — | 0.00 Bn |
| 148 | CANF | Can-Fite BioPharma Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.24 | 5.93 | 0.00 Bn |
| 149 | UPC | Universe Pharmaceuticals INC | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | -1,490.23 Bn |
| 150 | ENSC | Ensysce Biosciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | 0.00 Bn |
| 151 | MTNB | Matinas BioPharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.16 | — | 0.00 Bn |
| 152 | SKVI | Skinvisible, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.05 | 54.04 | 0.00 Bn |
| 153 | SPRC | SciSparc Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.05 | 0.76 | 0.00 Bn |
| 154 | NCEL | NewcelX Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.06 | — | 0.00 Bn |
| 155 | GLMD | Galmed Pharmaceuticals Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | 0.00 Bn |
| 156 | JAGX | Jaguar Health, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.01 | 0.01 | -0.01 Bn |
| 157 | CDT | CDT Equity Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.01 | — | 0.00 Bn |
| 158 | GCAN | Trafalgar International, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.77 | — | 0.00 Bn |
| 159 | CINGW | Cingulate Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | — | 0.00 Bn |
| 160 | SXTC | China SXT Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | 0.03 | -0.03 Bn |
| 161 | CMND | Clearmind Medicine Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | — | -0.01 Bn |
| 162 | CVX | Chevron Corp | secondary | E-01 | Oil and Gas Upstream | EG-01 | 419.94 Bn | 20.09 | 1.95 | 411.41 Bn |
| 163 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 180.55 Bn | -62.36 | 5.93 | 177.37 Bn |
| 164 | GLW | Corning Inc /Ny | secondary | M-02 | Chemicals | MG-01 | 145.51 Bn | 70.16 | 8.58 | 143.00 Bn |
| 165 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 132.28 Bn | 30.03 | 10.51 | 124.42 Bn |
| 166 | ISRG | Intuitive Surgical Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 124.64 Bn | 39.47 | 11.30 | 119.43 Bn |
| 167 | MDT | Medtronic plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 118.74 Bn | 22.53 | 3.16 | 109.92 Bn |
| 168 | MCK | Mckesson Corp | secondary | H-19 | Healthcare Payers and Distributors | HG-05 | 106.10 Bn | 20.02 | 0.26 | 100.93 Bn |
| 169 | PSX | Phillips 66 | secondary | E-01 | Oil and Gas Upstream | EG-01 | 104.08 Bn | 14.47 | 0.67 | 99.98 Bn |
| 170 | SHW | Sherwin Williams Co | secondary | M-03 | Chemicals | MG-01 | 78.88 Bn | 29.34 | 3.23 | 78.58 Bn |
| 171 | ECL | Ecolab Inc. | secondary | I-38 | Environmental Equipment | IG-09 | 77.14 Bn | 37.57 | 4.58 | 72.01 Bn |
| 172 | HON | Honeywell International Inc | secondary | I-01 | Aerospace and Defense | IG-01 | 65.44 Bn | 8.05 | 1.72 | 56.24 Bn |
| 173 | CAH | Cardinal Health Inc | secondary | H-19 | Healthcare Payers and Distributors | HG-05 | 56.82 Bn | 33.33 | 0.22 | 51.97 Bn |
| 174 | BDX | Becton Dickinson & Co | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 49.51 Bn | 52.56 | 2.13 | 48.65 Bn |
| 175 | TEVA | Teva Pharmaceutical Industries Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.77 Bn | 61.46 | 2.47 | 39.12 Bn |
| 176 | LYB | LyondellBasell Industries N.V. | secondary | M-01 | Chemicals | MG-01 | 41.56 Bn | -120.45 | 1.33 | 38.93 Bn |
| 177 | ALC | Alcon Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 33.93 Bn | 52.77 | 3.15 | 32.48 Bn |
| 178 | DXCM | Dexcom Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 32.38 Bn | 32.39 | 6.52 | 30.43 Bn |
| 179 | GEHC | GE HealthCare Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 30.05 Bn | 14.65 | 1.41 | 27.95 Bn |
| 180 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 29.89 Bn | -20.14 | 2,736.81 | 29.89 Bn |
| 181 | MDLN | Medline Inc. | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 29.85 Bn | 28.90 | 1.04 | 27.17 Bn |
| 182 | ATI | Ati Inc | secondary | M-02 | Chemicals | MG-01 | 28.16 Bn | 57.60 | 5.97 | 27.38 Bn |
| 183 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 27.14 Bn | -31.01 | 23.86 | 25.98 Bn |
| 184 | Q | Qnity Electronics, Inc. | secondary | M-02 | Chemicals | MG-01 | 25.77 Bn | 42.46 | 4.95 | 24.81 Bn |
| 185 | PPG | Ppg Industries Inc | secondary | M-03 | Chemicals | MG-01 | 24.31 Bn | 15.38 | 1.48 | 22.72 Bn |
| 186 | WST | West Pharmaceutical Services Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 24.00 Bn | 43.68 | 7.21 | 23.56 Bn |
| 187 | IFF | International Flavors & Fragrances Inc | secondary | M-02 | Chemicals | MG-01 | 21.69 Bn | 74.26 | 2.17 | 21.12 Bn |
| 188 | STE | STERIS plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 21.16 Bn | 26.19 | 3.50 | 20.68 Bn |
| 189 | VTRS | Viatris Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.25 Bn | -46.88 | 1.31 | 18.37 Bn |
| 190 | MKSI | Mks Inc | secondary | T-03 | Semiconductors | TG-01 | 17.98 Bn | 73.68 | 4.14 | 17.37 Bn |
| 191 | DD | DuPont de Nemours, Inc. | secondary | M-02 | Chemicals | MG-01 | 17.75 Bn | 95.94 | 2.54 | 16.01 Bn |
| 192 | NDSN | Nordson Corp | secondary | I-04 | Machinery | IG-02 | 17.61 Bn | 31.71 | 5.91 | 17.49 Bn |
| 193 | SOLV | Solventum Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 15.42 Bn | 10.75 | 1.86 | 15.02 Bn |
| 194 | FN | Fabrinet | secondary | T-14 | Computer Hardware | TG-02 | 15.14 Bn | 32.01 | 3.26 | 14.27 Bn |
| 195 | ALB | Albemarle Corp | secondary | M-11 | Metals and Mining | MG-02 | 15.02 Bn | 72.48 | 2.54 | 13.39 Bn |
| 196 | BWXT | BWX Technologies, Inc. | secondary | I-39 | Clean Energy Equipment | IG-10 | 14.55 Bn | 40.86 | 4.14 | 13.94 Bn |
| 197 | COO | Cooper Companies, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 13.10 Bn | 55.55 | 3.10 | 12.96 Bn |
| 198 | AVY | Avery Dennison Corp | secondary | M-02 | Chemicals | MG-01 | 13.03 Bn | 18.49 | 1.41 | 12.81 Bn |
| 199 | BAX | Baxter International Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 12.94 Bn | 562.52 | 1.17 | 10.79 Bn |
| 200 | RPM | Rpm International Inc/De/ | secondary | M-03 | Chemicals | MG-01 | 12.86 Bn | 19.42 | 1.64 | 12.55 Bn |
| 201 | GKOS | GLAUKOS Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.71 Bn | -67.99 | 17.47 | 10.59 Bn |
| 202 | PRAX | Praxis Precision Medicines, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 10.24 Bn | -26.84 | — | 9.48 Bn |
| 203 | AVTR | Avantor, Inc. | secondary | I-31 | Distribution and Rental | IG-07 | 10.09 Bn | -17.45 | 1.54 | 9.78 Bn |
| 204 | WLK | Westlake Corp | secondary | M-01 | Chemicals | MG-01 | 9.25 Bn | -7.77 | 0.82 | 7.40 Bn |
| 205 | VIAV | Viavi Solutions Inc. | secondary | T-15 | Computer Hardware | TG-02 | 8.97 Bn | -287.39 | 5.91 | 8.32 Bn |
| 206 | ESI | Element Solutions Inc | secondary | M-02 | Chemicals | MG-01 | 8.77 Bn | 49.06 | 2.78 | 8.58 Bn |
| 207 | EMN | Eastman Chemical Co | secondary | M-02 | Chemicals | MG-01 | 7.92 Bn | 11.86 | 0.89 | 7.23 Bn |
| 208 | ATR | Aptargroup, Inc. | secondary | I-04 | Machinery | IG-02 | 7.81 Bn | 21.53 | 1.99 | 7.62 Bn |
| 209 | TWST | Twist Bioscience Corp | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 7.77 Bn | -56.80 | 17.99 | 7.60 Bn |
| 210 | ICL | ICL Group Ltd. | secondary | M-04 | Chemicals | MG-01 | 7.58 Bn | 22.96 | 0.98 | 6.91 Bn |
| 211 | SASOF | Sasol Ltd | secondary | E-01 | Oil and Gas Upstream | EG-01 | 7.01 Bn | 9.20 | 0.43 | 4.43 Bn |
| 212 | HXL | Hexcel Corp /De/ | secondary | M-02 | Chemicals | MG-01 | 6.84 Bn | 44.53 | 3.46 | 6.77 Bn |
| 213 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.36 Bn | -39.04 | 1.20 | 5.99 Bn |
| 214 | MMED | MiniMed Group, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.36 Bn | -20.38 | 1.99 | 6.15 Bn |
| 215 | INGR | Ingredion Inc | secondary | S-07 | Agribusiness | SG-03 | 6.35 Bn | 10.61 | 0.88 | 5.40 Bn |
| 216 | BLRX | BioLineRx Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.31 Bn | -704.68 | 4,533.84 | 6.31 Bn |
| 217 | NOVT | Novanta Inc | secondary | I-04 | Machinery | IG-02 | 6.06 Bn | 114.58 | 5.89 | 5.34 Bn |
| 218 | TFX | Teleflex Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 5.92 Bn | -5.26 | 2.63 | 5.62 Bn |
| 219 | SXT | Sensient Technologies Corp | secondary | M-02 | Chemicals | MG-01 | 5.61 Bn | 36.16 | 3.30 | 5.58 Bn |
| 220 | STVN | Stevanato Group S.p.A. | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 5.54 Bn | 35.30 | 3.88 | 5.43 Bn |
| 221 | AMRX | Amneal Pharmaceuticals, Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 5.49 Bn | 25.50 | 1.76 | 5.36 Bn |
| 222 | BCPC | Balchem Corp | secondary | M-02 | Chemicals | MG-01 | 5.42 Bn | 32.95 | 4.99 | 5.35 Bn |
| 223 | MTRN | MATERION Corp | secondary | M-16 | Metals and Mining | MG-02 | 5.33 Bn | 59.10 | 2.54 | 5.31 Bn |
| 224 | PRM | Perimeter Solutions, Inc. | secondary | I-04 | Machinery | IG-02 | 5.21 Bn | -15.35 | 6.88 | 5.13 Bn |
| 225 | MMSI | Merit Medical Systems Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 5.19 Bn | 35.65 | 3.29 | 4.74 Bn |
| 226 | ERAS | Erasca, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.06 Bn | -17.63 | — | 5.06 Bn |
| 227 | CSW | Csw Industrials, Inc. | secondary | I-14 | Construction Products | IG-03 | 4.99 Bn | — | — | 4.95 Bn |
| 228 | CE | Celanese Corp | secondary | M-01 | Chemicals | MG-01 | 4.89 Bn | -4.23 | 0.50 | 3.53 Bn |
| 229 | FMCQF | Fresenius Medical Care AG | secondary | H-14 | Healthcare Providers | HG-04 | 4.79 Bn | 4.57 | 0.17 | 4.09 Bn |
| 230 | CLMT | Calumet, Inc. /DE | secondary | M-02 | Chemicals | MG-01 | 4.77 Bn | -34.86 | 1.04 | 4.62 Bn |
| 231 | HAE | Haemonetics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.58 Bn | 47.54 | 3.39 | 4.35 Bn |
| 232 | LIVN | LivaNova PLC | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.35 Bn | 22.96 | 2.96 | 3.84 Bn |
| 233 | AXTI | Axt Inc | secondary | T-04 | Semiconductors | TG-01 | 4.27 Bn | -2,828.96 | 36.67 | 3.49 Bn |
| 234 | CBT | Cabot Corp | secondary | M-02 | Chemicals | MG-01 | 4.15 Bn | 18.77 | 1.14 | 3.90 Bn |
| 235 | ICUI | Icu Medical Inc/De | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 4.05 Bn | 121.37 | 1.88 | 3.75 Bn |
| 236 | DNLI | Denali Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.03 Bn | -7.88 | 1,117.96 | 4.03 Bn |
| 237 | RCUS | Arcus Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.59 Bn | -7.80 | 30.67 | 2.89 Bn |
| 238 | PLSE | Pulse Biosciences, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 3.50 Bn | -43.41 | 4,464.46 | 3.50 Bn |
| 239 | ASH | Ashland Inc. | secondary | M-02 | Chemicals | MG-01 | 3.31 Bn | 14.41 | 1.80 | 2.87 Bn |
| 240 | IMNM | Immunome Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.98 Bn | -11.04 | 593.06 | 2.46 Bn |
| 241 | TMDX | TransMedics Group, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.95 Bn | 17.21 | 4.41 | 2.47 Bn |
| 242 | NRIX | Nurix Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.92 Bn | -8.56 | 79.43 | 2.48 Bn |
| 243 | FUL | Fuller H B Co | secondary | M-03 | Chemicals | MG-01 | 2.85 Bn | 19.31 | 0.81 | 2.74 Bn |
| 244 | ZLAB | Zai Lab Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.83 Bn | -15.02 | 6.29 | 2.12 Bn |
| 245 | WTTR | Select Water Solutions, Inc. | secondary | E-10 | Oilfield Services and Equipment | EG-04 | 2.80 Bn | 87.28 | 1.96 | 2.77 Bn |
| 246 | KWR | Quaker Chemical Corp | secondary | M-02 | Chemicals | MG-01 | 2.72 Bn | 33.75 | 1.38 | 2.56 Bn |
| 247 | CURLF | Curaleaf Holdings, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 2.68 Bn | -22.58 | 2.05 | 2.58 Bn |
| 248 | SLS | SELLAS Life Sciences Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.65 Bn | -81.53 | — | 2.65 Bn |
| 249 | ATRC | AtriCure, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.58 Bn | 244.49 | 4.53 | 2.41 Bn |
| 250 | HWKN | Hawkins Inc | secondary | M-02 | Chemicals | MG-01 | 2.58 Bn | 31.96 | 2.33 | 2.57 Bn |
| 251 | NGVT | Ingevity Corp | secondary | M-02 | Chemicals | MG-01 | 2.40 Bn | 44.39 | 2.07 | 2.21 Bn |
| 252 | BHC | Bausch Health Companies Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.39 Bn | -2.19 | 0.22 | 0.56 Bn |
| 253 | ROG | Rogers Corp | secondary | M-02 | Chemicals | MG-01 | 2.32 Bn | 74.09 | 2.78 | 2.11 Bn |
| 254 | BCRX | Biocryst Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.32 Bn | -6.02 | 4.33 | 1.96 Bn |
| 255 | IOSP | Innospec Inc. | secondary | M-02 | Chemicals | MG-01 | 2.29 Bn | 19.97 | 1.24 | 2.04 Bn |
| 256 | CC | Chemours Co | secondary | M-01 | Chemicals | MG-01 | 2.29 Bn | -7.51 | 0.40 | 1.62 Bn |
| 257 | BHVN | Biohaven Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.22 Bn | -3.79 | — | 1.96 Bn |
| 258 | UFPT | Ufp Technologies Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 2.18 Bn | 30.21 | 3.46 | 2.18 Bn |
| 259 | MTX | Minerals Technologies Inc | secondary | M-16 | Metals and Mining | MG-02 | 2.18 Bn | -7.97 | 1.01 | 1.83 Bn |
| 260 | XRAY | DENTSPLY SIRONA Inc. | secondary | H-09 | Medical Devices and Diagnostics | HG-02 | 2.17 Bn | -3.96 | 0.60 | 1.93 Bn |
| 261 | ZBIO | Zenas BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.07 Bn | -4.97 | 2,065.67 | 2.07 Bn |
| 262 | OLN | OLIN Corp | secondary | M-01 | Chemicals | MG-01 | 2.01 Bn | -10.20 | 0.30 | 1.83 Bn |
| 263 | EPAC | Enerpac Tool Group Corp | secondary | I-08 | Machinery | IG-02 | 1.89 Bn | 20.28 | 2.98 | 1.78 Bn |
| 264 | LMAT | Lemaitre Vascular Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.82 Bn | 27.70 | 6.93 | 1.44 Bn |
| 265 | AAPG | Ascentage Pharma Group International | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.66 Bn | -9.11 | 20.12 | 1.38 Bn |
| 266 | BAK | Braskem Sa | secondary | M-01 | Chemicals | MG-01 | 1.63 Bn | -0.82 | 0.11 | -0.57 Bn |
| 267 | PAHC | Phibro Animal Health Corp | secondary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 1.51 Bn | 15.10 | 0.99 | 1.42 Bn |
| 268 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.50 Bn | -3.25 | 2.10 | 1.21 Bn |
| 269 | ANIP | Ani Pharmaceuticals Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.49 Bn | 13.78 | 1.52 | 1.13 Bn |
| 270 | SCL | Stepan Co | secondary | M-02 | Chemicals | MG-01 | 1.42 Bn | -3,229.52 | 0.58 | 1.31 Bn |
| 271 | CNMD | CONMED Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.42 Bn | 25.10 | 1.03 | 1.38 Bn |
| 272 | AVBP | ArriVent BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.41 Bn | -8.62 | — | 1.41 Bn |
| 273 | OMER | Omeros Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.38 Bn | 80.85 | 35.91 | 1.38 Bn |
| 274 | TNDM | Tandem Diabetes Care Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.36 Bn | -21.48 | 1.31 | 0.90 Bn |
| 275 | IART | Integra Lifesciences Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.25 Bn | -172.61 | 0.76 | 0.98 Bn |
| 276 | CRVS | Corvus Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.23 Bn | -25.71 | — | 1.01 Bn |
| 277 | AORT | Artivion, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.22 Bn | -386.79 | 2.60 | 1.15 Bn |
| 278 | PRCT | PROCEPT BioRobotics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.19 Bn | -10.35 | 3.51 | 0.91 Bn |
| 279 | AVNS | Avanos Medical, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.17 Bn | -15.62 | 1.63 | 1.10 Bn |
| 280 | ECVT | Ecovyst Inc. | secondary | M-01 | Chemicals | MG-01 | 1.13 Bn | -18.23 | 1.29 | 1.04 Bn |
| 281 | IRMD | Iradimed Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.08 Bn | 46.81 | 12.46 | 1.02 Bn |
| 282 | ACDC | ProFrac Holding Corp. | secondary | E-10 | Oilfield Services and Equipment | EG-04 | 0.99 Bn | -2.40 | 0.55 | 0.97 Bn |
| 283 | MNPR | Monopar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.97 Bn | -70.11 | — | 0.92 Bn |
| 284 | FTK | Flotek Industries Inc/Cn/ | secondary | M-02 | Chemicals | MG-01 | 0.97 Bn | 25.46 | 3.30 | 0.96 Bn |
| 285 | INMD | InMode Ltd. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.96 Bn | 11.19 | 2.57 | 0.48 Bn |
| 286 | BVS | Bioventus Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.93 Bn | 15.18 | 1.60 | 0.90 Bn |
| 287 | CBLL | Ceribell, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.93 Bn | -14.06 | 9.10 | 0.80 Bn |
| 288 | KOP | Koppers Holdings Inc. | secondary | M-02 | Chemicals | MG-01 | 0.90 Bn | -10.40 | 0.48 | 0.86 Bn |
| 289 | KODK | Eastman Kodak Co | secondary | I-30 | Business Services | IG-06 | 0.90 Bn | -13.59 | 0.79 | 0.58 Bn |
| 290 | BBNX | Beta Bionics, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.85 Bn | -11.59 | 7.11 | 0.67 Bn |
| 291 | LWLG | Lightwave Logic, Inc. | secondary | M-02 | Chemicals | MG-01 | 0.83 Bn | -65.48 | 5,683.13 | 0.83 Bn |
| 292 | ACRS | Aclaris Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.83 Bn | -10.46 | 101.25 | 0.83 Bn |
| 293 | SIBN | SI-BONE, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.83 Bn | -56.97 | 3.89 | 0.69 Bn |
| 294 | DQ | Daqo New Energy Corp. | secondary | M-01 | Chemicals | MG-01 | 0.81 Bn | -4.25 | 1.47 | 0.01 Bn |
| 295 | AHCO | AdaptHealth Corp. | secondary | H-15 | Healthcare Providers | HG-04 | 0.78 Bn | -3.51 | 0.24 | 0.74 Bn |
| 296 | MLAB | Mesa Laboratories Inc /Co/ | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.71 Bn | 201.37 | 2.84 | 0.68 Bn |
| 297 | MATV | Mativ Holdings, Inc. | secondary | M-02 | Chemicals | MG-01 | 0.70 Bn | 7.77 | 0.35 | 0.62 Bn |
| 298 | SSII | SS Innovations International, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.66 Bn | -42.94 | 12.56 | 0.64 Bn |
| 299 | ANGO | Angiodynamics Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.63 Bn | -17.15 | 1.97 | 0.58 Bn |
| 300 | OCS | Oculis Holding AG | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.61 Bn | -350,482.51 | — | 0.61 Bn |